Charles River Laboratories International Inc (CRL.N)
29 Aug 2014
|Market Cap (Mil.):||$2,758.61|
|Shares Outstanding (Mil.):||46.68|
BRUSSELS, March 13 - Belgian biotechnology group Galapagos said on Thursday it had agreed to sell its drug discovery service businesses to Charles River Laboratories International for up to 134 million euros ($186.3 million).
BRUSSELS, March 13 - Galapagos NV : * Charles River Laboratories to acquire Galapagos' argenta and biofocus service operations for up to EUR134 million * Says earnout of EUR5 million upon achievement of revenue target after 12 months * Management guidance for 2014 group revenues of EUR125 million and year end cash of EUR170 million * Says proceeds to be used to progress galapagos' pipeline * Charles River agrees to pay Galapagos immediate cash consideration of EUR129 million * Sa